China Universal Asset Management Company’s Oric Pharmaceuticals ORIC Stock Holding History

China Universal Asset Management Company’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$226K	Buy	17,809 +1,939	+12%	+$22K	0.02%	341
2025 Q4	$130K	Sell	15,870 -11,154	-41%	-$128K	0.01%	388
2025 Q3	$324K	Buy	27,024 +12,746	+89%	+$134K	0.03%	284
2025 Q2	$145K	Buy	14,278 +31	+0.2%	+$208	0.01%	337
2025 Q1	$79.5K	Sell	14,247 -716	-5%	-$6.26K	0.01%	376
2024 Q4	$121K	Buy	14,963 +1,395	+10%	+$12.8K	0.01%	374
2024 Q3	$139K	Buy	13,568 +5,646	+71%	+$55.8K	0.02%	328
2024 Q2	$56K	Sell	7,922 -5,000	-39%	-$44.8K	0.01%	348
2024 Q1	$178K	Buy	12,922 +6,617	+105%	+$78.6K	0.02%	305
2023 Q4	$58K	Buy	+6,305	New	+$45.6K	0.01%	354
2022 Q4	–	Sell	-370	Closed	-$1K	–	438
2022 Q3	$1K	Buy	+370	New	+$1.48K	﹤0.01%	405

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

China Universal Asset Management Company's ORIC Position: Q1 2026 in Review

China Universal Asset Management Company increased its Oric Pharmaceuticals (ORIC) stake by 12% in Q1 2026, buying an estimated $22K and bringing the position to 17,809 shares worth $226K. The position accounts for 0.02% of the portfolio, ranked #341.

China Universal Asset Management Company first reported a position in ORIC in Q3 2022 and has held it in 11 quarters since. The position peaked at $324K in Q3 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

China Universal Asset Management Company held 17,809 shares of Oric Pharmaceuticals worth $226K as of Q1 2026.
China Universal Asset Management Company bought 1,939 Oric Pharmaceuticals shares in Q1 2026, an estimated $22K.
Oric Pharmaceuticals made up 0.02% of China Universal Asset Management Company's portfolio in Q1 2026, its #341 holding.
China Universal Asset Management Company first reported a position in Oric Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
China Universal Asset Management Company's Oric Pharmaceuticals position peaked at $324K in Q3 2025.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.